ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,388Medicare Part D Prescriptions Filled, Including Refills

Rank: 39 out of 625

$823K Total Retail Price of All Prescriptions

Rank: 56 out of 625

624 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

12% of this provider’s 624 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 13,412 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
SIMVASTATIN 865 740 1 2
LEVOTHYROXINE SODIUM 698 597 2 3
AMLODIPINE BESYLATE 653 578 3 1
OMEPRAZOLE 525 468 4 6
PRAVASTATIN SODIUM 430 369 5 8
HYDROCODONE-ACETAMINOPHEN 417 264 S3 6 4
METOPROLOL TARTRATE 355 329 7 11
ATORVASTATIN CALCIUM 351 312 8 9
CRESTOR 283 266 9 17
LISINOPRIL 268 216 10 5
HYDROCHLOROTHIAZIDE 266 227 11 12
WARFARIN SODIUM 249 229 12 20
TRAMADOL HCL 249 213 12 16
FUROSEMIDE 245 215 14 7
METOPROLOL SUCCINATE 242 234 15 15
FENOFIBRATE 219 191 16 59
METFORMIN HCL 215 185 17 10
DONEPEZIL HCL 206 206 18 33
ZOLPIDEM TARTRATE 205 204 19 13
CITALOPRAM HBR 203 166 20 24
LOSARTAN-HYDROCHLOROTHIAZIDE 202 193 21 38
LISINOPRIL-HYDROCHLOROTHIAZIDE 184 143 22 27
ALENDRONATE SODIUM 173 169 23 34
NEXIUM 168 163 24 21
KLOR-CON M20 163 137 25 47
LOSARTAN POTASSIUM 158 153 26 18
ALLOPURINOL 156 143 27 29
DIOVAN HCT 145 130 28 52
TAMSULOSIN HCL 144 144 29 36
ATENOLOL 136 117 30 22
FLUTICASONE PROPIONATE 129 106 31 32
POTASSIUM CHLORIDE 128 122 32 19
GLYBURIDE-METFORMIN HCL 127 108 R 33 125
LANTUS 123 110 34 54
ESCITALOPRAM OXALATE 115 100 35 67
NAMENDA 113 113 36 45
CLOPIDOGREL 112 110 37 30
BENAZEPRIL HCL 112 109 37 35
TRIAMTERENE-HCTZ 111 84 39 53
GLIPIZIDE 109 106 40 56
GABAPENTIN 108 106 41 14
GLIPIZIDE ER 104 101 42 68
AZITHROMYCIN 101 85 43 40
DILTIAZEM ER 94 94 44 121
PANTOPRAZOLE SODIUM 93 81 45 44
AMLODIPINE BESYLATE-BENAZEPRIL 93 87 45 48
CLONIDINE HCL 91 64 47 50
LIPITOR 89 75 48 75
PLAVIX 89 89 48 43
BYSTOLIC 89 89 48 97
FLUOXETINE HCL 88 74 51 62
AMITRIPTYLINE HCL 82 56 R 52 61
CARVEDILOL 81 69 53 23
INSULIN SYRINGE 80 69 54 77
ZETIA 79 79 55 66
SERTRALINE HCL 76 62 56 26
DIOVAN 69 59 57 28
DIGOXIN 69 68 57 55
TRAZODONE HCL 68 59 59 51
COLCRYS 64 53 60 117
LOVAZA 63 59 61 153
NOVOLIN 70-30 63 54 61 154
CIPROFLOXACIN HCL 63 57 61 60
GLIPIZIDE XL 60 53 64 83
MELOXICAM 52 27 65 31
LEXAPRO 51 45 66 196
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 20, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.